Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common Stock
Shares outstanding
59,119,327
Total 13F shares
54,377,164
Share change
+1,355,107
Total reported value
$1,000,565,489
Put/Call ratio
165%
Price per share
$18.40
Number of holders
175
Value change
+$5,340,845
Number of buys
109
Number of sells
80

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q1 2019

As of 31 Mar 2019, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 175 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,377,164 shares. The largest 10 holders included BlackRock Inc., Palo Alto Investors LP, Consonance Capital Management LP, VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MACQUARIE GROUP LTD, GLENMEDE TRUST CO NA, Invesco Ltd., and Stonepine Capital Management, LLC. This page lists 175 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.